Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 1 Prostatic Neoplasms 1 Kidney Neoplasms 1 Diverticulitis 1 Crohn Disease 1 Colonic Polyps 1 Colonic Neoplasms 1 Colitis, Ulcerative 1

Interventions

Docetaxel 292 Prednisone 240 enzalutamide 193 Leuprolide 185 Radiotherapy 179 Abiraterone Acetate 169 Magnetic Resonance Spectroscopy 163 bicalutamide 141 Goserelin 138 Androgen Antagonists 121 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108 Radiosurgery 108 apalutamide 92 gallium 68 PSMA-11 81 abiraterone 81 Specimen Handling 73 darolutamide 65 Surveys and Questionnaires 64 Gonadotropin-Releasing Hormone 63 Triptorelin Pamoate 58 Radiation 57 Biopsy 57 Brachytherapy 54 cabazitaxel 52 Standard of Care 51 Radiotherapy, Intensity-Modulated 51 Zoledronic Acid 50 pembrolizumab 49 luprolide acetate gel depot 49 Flutamide 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Hydroxyethyl Starch Derivatives × Clear all

NCT01486563 2013-09-17

VORA

Regional Hospital Holstebro

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡